披露对对患有炎症性肠道疾病的个人实施耻辱的影响
Chalé M Jacks1, Lauren A Stutts2
1Davidson College, Davidson, USA.
Journal of clinical psychology in medical settings
|March 5, 2025
概括
患有炎症性肠病 (IBD) 的人可能会在披露他们的病情时面临较少的耻辱. 关于IBD的公共教育也可以减少对患有该疾病的人的歧视性待遇.
科学领域:
- 胃肠病学 胃肠病学
- 社会心理学 社会心理学
背景情况:
- 患有炎症性肠病 (IBD) 的人经常遇到耻辱.
- 以前的研究表明,疾病披露与减少实施的耻辱之间存在联系,但实验数据有限.
研究的目的:
- 实验性地研究炎症性肠病 (IBD) 披露对实施的耻辱的影响,使用基于图片的方法.
- 评估不同披露情景 (披露与不披露) 如何影响人们对耻辱的看法.
主要方法:
- 一个随机的实验设计,涉及244名美国成年人.
- 参与者被分配阅读描绘IBD披露,IBD非披露或控制场景 (没有IBD) 的小幅画.
- 措施包括颁布的耻辱,IBD知识和IBD熟悉度在工作场所,社会和娱乐场所.
主要成果:
- 在不披露IBD的情况下,与披露或不披露IBD细节相比,报告了更高的颁布的耻辱感.
- 娱乐环境引起的耻辱比工作场所或社会环境更大.
- 颁布的耻辱表现出与IBD知识的负相关性.
结论:
- 披露IBD可能会减少他人对您的耻辱感.
- 关于IBD的公共教育举措对于缓解被颁布的耻辱和改善患有该病的人的社会融合至关重要.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
91
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
91
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
219
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
219
Inflammatory Bowel Disease II: Crohn's Disease
122
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
122
Chronic Bowel Disorders: Introduction
298
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
298
Irritable Bowel Syndrome I: Introduction
201
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
201
Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79


